Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate-ferredoxin oxidoreductase (PFOR) is a key enzyme in anaerobic metabolism, catalyzing the oxidative decarboxylation of pyruvate to acetyl-CoA and carbon dioxide, while reducing ferredoxin. This reaction is central to energy metabolism in many anaerobic bacteria and archaea, linking glycolysis to various metabolic pathways such as the Wood–Ljungdahl pathway for CO₂ fixation. It requires thiamine pyrophosphate (TPP), three [4Fe–4S] iron-sulfur clusters, and coenzyme A (CoA) as cofactors.
Oxidative decarboxylation of pyruvate to acetyl-CoA and carbon dioxide, while reducing ferredoxin
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate:ferredoxin oxidoreductase (None).